History

Mochida was established by Ryokichi (Mochida in Hongo, Bunkyo-ku, Tokyo.)

Started producing pharmaceuticals

Started producing and marketing Ogoko, an ophthalmicointment

Started producing and marketing Luestin, an injectable antiluetic

Developed Thrombrin, Japan's first organ-derived hemostatic agent

Completed and launched Pelanin, the first estrogen preparation developed in Japan

Launched Testinon, a male hormone preparation

Mochida Pharmaceutical Co., Ltd. was incorporated

Launched Sprase, the first hyaluronidase preparation developed in Japan

Launched Estropan, a complex natural female functional hormone

Succeeded in producing Thrombin, a hemostatic enzyme, in Japan

Launched Partan, a hemostatic drug that contributes to uterine contraction

Listed on the Second Section of the Tokyo Stock Exchange (TSE)

Nobuo Mochida was appointed president

Launched Gonavis, Japan's first immunological pregnancy test kit

Launched Kimotab, an anti-inkflammatoryenzyme preparation

Took part in "Life" Theme Pavilion at Japan World Exposition and exhibited DNA structure model

Established the Paramedical Division and entered the quasi-drugs business

Launched Gonavislide, a pregnancy test kit

Launched Uronase, a fibrinolytic enzyme preparation

Launched Skina Babe, baby bath oil

Established the Medical Electronics and Equipment Division

Completed and started operating the Shizuoka Plant

Completed and started operating the Saitama Plant

Listed on the First Section of the TSE

Completed and relocated to the new headquarters building in Yotsuya

Launched, SONOVISTA, the first ultrasonic diagnostic scanner developed in Japan

Received a Noteworthy Invention Testimonial from the Science and Technology Agency for the Medilaser balance-type surgical laser head

Launched Rocornal, a circulatory function activator

Launched Collage Cream, the first basic skin care product containing soluble collagen developed in Japan

Launched Medilaser-S, the first carbon dioxide laser surgical unit produced in Japan

Signed an agreement with Hayashibara Biochemical Laboratory, Inc. for joint research of interferon

Completed and opened the Fuji Central Research Laboratory (Gotemba)

Established the Mochida Memorial Foundation for Medical and Pharmaceutical Research

Their Imperial Highnesses Prince and Princess Takamatsu visited Fuji Central Research Laboratory

Launched Arasena-A, a treatment for viral encephalitis

Nobuo Mochida awarded the Medal with Purple Ribbon for research on the first surgical laser unit developed in Japan

Ei Mochida was appointed president

Launched Miraclid, the world's first ulinastatin preparation

Launched Florid-F injection for the treatment of deep-seated mycoses

Launched Grandaxin, an autonomic nerve regulator

Ei Mochida awarded the Medal with Purple Ribbon for R&D activities on an immunochemical diagnostic reagent

Launched the Collage Soap series of low-irritating soap formulated for each specific skin type

Launched Isoprinosine, a chemotherapeutic agent

Launched natural-type interferon preparations IFN α MOCHIDA 500 and IFN β MOCHIDA.

Launched Tecipul, a tetracyclic antidepressant

Completed Ohtawara Plant

Launched Mammotec, an auxiliary reagent for breast cancer diagnosis.

Launched Arasena-A Ointment, the first topical antiviral agent developed in Japan

Commenced JELIS (EBM study for Epadel)

Launched Atelec, a calcium channel blocker.

Naoyuki Mochida appointed president

Launched EPA preparations Epadel S 300 and 600

Launched low-dose oral contraceptives Ortho 777-28 and Ortho M-21

Launched Collage Furfur, the first shampoo containing antimycotic ingredients developed in Japan

Launched Gonastick 25, a pregnancy test kit

Launched Arasena-A Cream, an antiviral agent

Obtained the certification of ISO 14001 for Ohtawara Plant

Launched the Vitacollage series of health supplements

Launched Spurecur, a GnRH derivative preparation

Mochida Medical Systems Co., Ltd. commenced operations

Launched Liquid Thrombin Mochida Soft Bottle, a hemostatic agent

Launched the Collage S series of basic skin products

Mochida Healthcare Co., Ltd. commenced operations

Mochida Medical Systems Co., Ltd. commenced operations as Mochida Siemens Medical Systems Co., Ltd.
(Excluded from affiliated companies accounted for by the equity method in 2009.)

Launched Epadel S 900, a stick-type EPA preparation

Mochida Pharmaceutical Plant Co., Ltd. commenced operations

Results of JELIS (EBM study for Epadel) announced by American Heart Association (AHA)

Launched the Collage Whitening series, the first whitening skincare products for sensitive skin developed in Japan

Launched Collage Furfur Liquid Soap

Launched Beselna, the first treatment for condyloma acuminatum developed in Japan

Commenced co-promotion of Diovan , an antihypertensive. (Agreement terminated end of 2008.)

Launched Dinagest, a treatment for endometriosis

Launched Collage White Peel, an enzyme powder face wash

Launched Divigel transdermal estrogen gel

Launched Collage Furfur Next Shampoo and Rinse which contain antimycotic ingredients

Launched Gonastick W, a pregnancy test kit

Launched Lexapro, an anti-depressant

Launched Fastic, a fast-acting postprandial antihyperglycemic agent

Launched glucoriina, a food for specified health uses (FOSHU)

Launched a switch-OTC version of Epadel

Launched the Collage B.K.AGE series

Launched biosimilar Filgrastim BS MOCHIDA

Launched Tramcet tablets, an analgesic

Mochida Pharmaceutical Sales Co., Ltd. commenced operations

Launched Atedio tablets for treatment of hypertension

Renewed and relaunched the Collage Skincare series

Launched Treprost, a therapeutic agent for pulmonary arterial hypertension

Launched Lialda, a treatment for ulcerative colitis

Launched Calprotectin MOCHIDA, an in-vitro diagnostic agent for ulcerative colitis

Launched Doxil, an anticancer agent

Launched Goofice, a treatment for chronic constipation

Launched biosimilar Etanercept BS MA

Launched Collage Furfur Premium Shampoo

Launched Movicol, a treatment for chronic constipation

Launched the Collage Repair series

Launched biosimilar Teriparatide BS MOCHIDA

Launched Gonacard W, a pregnancy test kit

Launched Urece, a treatment of gout and hyperuricemia

Launch of DINAGEST Tablets 0.5 mg, a Treatment for Dysmenorrhea

Launched biosimilar Adalimumab BS MA

Shifted to the TSE Prime Market

Completed and started operating at the new headquarters building in Yotsuya

Launched Epadel EM, a self-emulsifying formulation of highly purified EPA

Launched Omvoh and Cortiment, a treatment for ulcerative colitis

Launched biosimilar Pegfilgrastim BS MOCHIDA